UniProt ID | DPYL2_HUMAN | |
---|---|---|
UniProt AC | Q16555 | |
Protein Name | Dihydropyrimidinase-related protein 2 | |
Gene Name | DPYSL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 572 | |
Subcellular Localization | Cytoplasm, cytosol . Cytoplasm, cytoskeleton . Membrane . Tightly but non-covalently associated with membranes. | |
Protein Description | Plays a role in neuronal development and polarity, as well as in axon growth and guidance, neuronal growth cone collapse and cell migration. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. May play a role in endocytosis.. | |
Protein Sequence | MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTSPAKQQAPPVRNLHQSGFSLSGAQIDDNIPRRTTQRIVAPPGGRANITSLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSYQGKKNI ------CCCCCCCCC | 26.60 | 21406692 | |
3 | Phosphorylation | -----MSYQGKKNIP -----CCCCCCCCCC | 21.71 | 18083107 | |
7 | Phosphorylation | -MSYQGKKNIPRITS -CCCCCCCCCCCCCC | 67.92 | 24719451 | |
13 | Phosphorylation | KKNIPRITSDRLLIK CCCCCCCCCCCEEEE | 26.34 | 28450419 | |
14 | Phosphorylation | KNIPRITSDRLLIKG CCCCCCCCCCEEEEC | 20.54 | 28450419 | |
20 | Acetylation | TSDRLLIKGGKIVND CCCCEEEECCEECCC | 62.67 | 25953088 | |
25 | Phosphorylation | LIKGGKIVNDDQSFY EEECCEECCCCCCCH | 7.97 | 24719451 | |
27 | Phosphorylation | KGGKIVNDDQSFYAD ECCEECCCCCCCHHE | 44.42 | - | |
30 | Phosphorylation | KIVNDDQSFYADIYM EECCCCCCCHHEEEE | 27.50 | 24076635 | |
32 | Phosphorylation | VNDDQSFYADIYMED CCCCCCCHHEEEECC | 14.49 | 24927040 | |
43 | Ubiquitination | YMEDGLIKQIGENLI EECCCCHHEECCCEE | 40.69 | - | |
54 | Phosphorylation | ENLIVPGGVKTIEAH CCEEECCCCCEEEEC | 16.21 | - | |
56 | Phosphorylation | LIVPGGVKTIEAHSR EEECCCCCEEEECCC | 47.24 | 24719451 | |
57 | Phosphorylation | IVPGGVKTIEAHSRM EECCCCCEEEECCCE | 22.95 | - | |
59 | Methylation | PGGVKTIEAHSRMVI CCCCCEEEECCCEEE | 45.63 | - | |
64 | Sulfoxidation | TIEAHSRMVIPGGID EEEECCCEEECCCCC | 3.43 | 30846556 | |
74 | Phosphorylation | PGGIDVHTRFQMPDQ CCCCCEEECCCCCCC | 32.78 | - | |
78 | Sulfoxidation | DVHTRFQMPDQGMTS CEEECCCCCCCCCCC | 3.48 | 21406390 | |
82 | Phosphorylation | RFQMPDQGMTSADDF CCCCCCCCCCCHHHH | 28.81 | - | |
83 | Phosphorylation | FQMPDQGMTSADDFF CCCCCCCCCCHHHHH | 1.91 | - | |
83 | Sulfoxidation | FQMPDQGMTSADDFF CCCCCCCCCCHHHHH | 1.91 | 30846556 | |
85 | Phosphorylation | MPDQGMTSADDFFQG CCCCCCCCHHHHHHH | 22.32 | - | |
94 | Phosphorylation | DDFFQGTKAALAGGT HHHHHHHHHHHCCCC | 38.19 | - | |
97 | Phosphorylation | FQGTKAALAGGTTMI HHHHHHHHCCCCEEE | 5.63 | - | |
101 | Phosphorylation | KAALAGGTTMIIDHV HHHHCCCCEEEEEEE | 16.57 | - | |
102 | Phosphorylation | AALAGGTTMIIDHVV HHHCCCCEEEEEEEC | 15.06 | 22798277 | |
103 | Sulfoxidation | ALAGGTTMIIDHVVP HHCCCCEEEEEEECC | 2.25 | 30846556 | |
107 | Phosphorylation | GTTMIIDHVVPEPGT CCEEEEEEECCCCCC | 16.44 | 24719451 | |
152 | Sulfoxidation | HKGIQEEMEALVKDH HHHHHHHHHHHHHHH | 3.43 | 21406390 | |
168 | Sulfoxidation | VNSFLVYMAFKDRFQ CCCHHHHHHCCCCCC | 2.49 | 30846556 | |
241 | O-linked_Glycosylation | EAVNRAITIANQTNC HHHHHHHHHHHHCCC | 17.04 | 28510447 | |
246 | Phosphorylation | AITIANQTNCPLYIT HHHHHHHCCCCEEEE | 38.30 | 24076635 | |
251 | Phosphorylation | NQTNCPLYITKVMSK HHCCCCEEEEEECCC | 7.53 | 28152594 | |
253 | Phosphorylation | TNCPLYITKVMSKSS CCCCEEEEEECCCCH | 12.20 | 28152594 | |
254 | Acetylation | NCPLYITKVMSKSSA CCCEEEEEECCCCHH | 26.78 | 25953088 | |
254 | Ubiquitination | NCPLYITKVMSKSSA CCCEEEEEECCCCHH | 26.78 | - | |
258 | Succinylation | YITKVMSKSSAEVIA EEEEECCCCHHHHHH | 30.27 | - | |
258 | Succinylation | YITKVMSKSSAEVIA EEEEECCCCHHHHHH | 30.27 | - | |
258 | Ubiquitination | YITKVMSKSSAEVIA EEEEECCCCHHHHHH | 30.27 | - | |
259 | Phosphorylation | ITKVMSKSSAEVIAQ EEEECCCCHHHHHHH | 27.72 | - | |
269 | Ubiquitination | EVIAQARKKGTVVYG HHHHHHHHCCEEEEC | 59.58 | - | |
270 | Ubiquitination | VIAQARKKGTVVYGE HHHHHHHCCEEEECC | 55.02 | - | |
280 | Phosphorylation | VVYGEPITASLGTDG EEECCCEEEEECCCC | 22.40 | - | |
282 | Phosphorylation | YGEPITASLGTDGSH ECCCEEEEECCCCCC | 20.77 | 28348404 | |
285 | Phosphorylation | PITASLGTDGSHYWS CEEEEECCCCCCCCC | 42.34 | 28348404 | |
288 | Phosphorylation | ASLGTDGSHYWSKNW EEECCCCCCCCCCCH | 19.06 | 25159151 | |
290 | Phosphorylation | LGTDGSHYWSKNWAK ECCCCCCCCCCCHHH | 17.05 | 27251275 | |
292 | Phosphorylation | TDGSHYWSKNWAKAA CCCCCCCCCCHHHHE | 14.67 | 24076635 | |
293 | Acetylation | DGSHYWSKNWAKAAA CCCCCCCCCHHHHEE | 42.22 | 25953088 | |
293 | Ubiquitination | DGSHYWSKNWAKAAA CCCCCCCCCHHHHEE | 42.22 | - | |
303 | Phosphorylation | AKAAAFVTSPPLSPD HHHEEEECCCCCCCC | 29.12 | 20068231 | |
304 | Phosphorylation | KAAAFVTSPPLSPDP HHEEEECCCCCCCCC | 21.15 | 20068231 | |
308 | Phosphorylation | FVTSPPLSPDPTTPD EECCCCCCCCCCCHH | 32.79 | 21406692 | |
345 | Acetylation | TAQKAVGKDNFTLIP CHHHHHCCCCEEEEC | 42.79 | 66723665 | |
345 | Ubiquitination | TAQKAVGKDNFTLIP CHHHHHCCCCEEEEC | 42.79 | - | |
358 | Phosphorylation | IPEGTNGTEERMSVI ECCCCCCCCHHEEEE | 36.42 | - | |
363 | Phosphorylation | NGTEERMSVIWDKAV CCCCHHEEEEEEEEE | 19.37 | 25332170 | |
368 | 2-Hydroxyisobutyrylation | RMSVIWDKAVVTGKM HEEEEEEEEEEECCC | 28.25 | - | |
368 | Ubiquitination | RMSVIWDKAVVTGKM HEEEEEEEEEEECCC | 28.25 | - | |
374 | Ubiquitination | DKAVVTGKMDENQFV EEEEEECCCCCCCEE | 33.54 | - | |
390 | Ubiquitination | VTSTNAAKVFNLYPR EEECCHHHHCCCCCC | 44.97 | - | |
393 | Phosphorylation | TNAAKVFNLYPRKGR CCHHHHCCCCCCCCC | 41.47 | 27251275 | |
416 | Phosphorylation | LVIWDPDSVKTISAK EEEECCCCCEEEEEE | 30.79 | - | |
418 | Ubiquitination | IWDPDSVKTISAKTH EECCCCCEEEEEECC | 44.06 | - | |
423 | Acetylation | SVKTISAKTHNSSLE CCEEEEEECCCCCCC | 43.45 | 25953088 | |
423 | Ubiquitination | SVKTISAKTHNSSLE CCEEEEEECCCCCCC | 43.45 | - | |
424 | Phosphorylation | VKTISAKTHNSSLEY CEEEEEECCCCCCCE | 26.46 | 30108239 | |
427 | Phosphorylation | ISAKTHNSSLEYNIF EEEECCCCCCCEEEE | 28.79 | 30108239 | |
428 | Phosphorylation | SAKTHNSSLEYNIFE EEECCCCCCCEEEEC | 30.45 | 28464451 | |
431 | Phosphorylation | THNSSLEYNIFEGME CCCCCCCEEEECCCC | 20.89 | 30108239 | |
437 | Sulfoxidation | EYNIFEGMECRGSPL CEEEECCCCCCCCCE | 3.28 | 30846556 | |
442 | Phosphorylation | EGMECRGSPLVVISQ CCCCCCCCCEEEEEC | 8.84 | 30266825 | |
448 | Phosphorylation | GSPLVVISQGKIVLE CCCEEEEECCEEEEC | 22.67 | 30266825 | |
458 | Phosphorylation | KIVLEDGTLHVTEGS EEEECCCCEEEEECC | 26.47 | 24076635 | |
462 | Phosphorylation | EDGTLHVTEGSGRYI CCCCEEEEECCCCCC | 24.71 | 19060867 | |
465 | Phosphorylation | TLHVTEGSGRYIPRK CEEEEECCCCCCCCC | 17.54 | 28857561 | |
472 | Ubiquitination | SGRYIPRKPFPDFVY CCCCCCCCCCCCHHH | 45.73 | 21890473 | |
472 | Ubiquitination | SGRYIPRKPFPDFVY CCCCCCCCCCCCHHH | 45.73 | 21890473 | |
472 | Malonylation | SGRYIPRKPFPDFVY CCCCCCCCCCCCHHH | 45.73 | 26320211 | |
472 | Ubiquitination | SGRYIPRKPFPDFVY CCCCCCCCCCCCHHH | 45.73 | 21890473 | |
479 | Phosphorylation | KPFPDFVYKRIKARS CCCCCHHHHHHHHHH | 8.44 | 19276087 | |
480 | 2-Hydroxyisobutyrylation | PFPDFVYKRIKARSR CCCCHHHHHHHHHHH | 42.20 | - | |
492 | Methylation | RSRLAELRGVPRGLY HHHHHHHHCCCCCCC | 35.25 | - | |
499 | Phosphorylation | RGVPRGLYDGPVCEV HCCCCCCCCCCEEEE | 22.98 | 21945579 | |
504 | S-nitrosocysteine | GLYDGPVCEVSVTPK CCCCCCEEEEEEECC | 4.87 | - | |
504 | S-nitrosylation | GLYDGPVCEVSVTPK CCCCCCEEEEEEECC | 4.87 | 19483679 | |
504 | S-palmitoylation | GLYDGPVCEVSVTPK CCCCCCEEEEEEECC | 4.87 | 26865113 | |
507 | O-linked_Glycosylation | DGPVCEVSVTPKTVT CCCEEEEEEECCCCC | 9.66 | 28510447 | |
507 | Phosphorylation | DGPVCEVSVTPKTVT CCCEEEEEEECCCCC | 9.66 | 21945579 | |
509 | O-linked_Glycosylation | PVCEVSVTPKTVTPA CEEEEEEECCCCCCC | 16.15 | 28510447 | |
509 | Phosphorylation | PVCEVSVTPKTVTPA CEEEEEEECCCCCCC | 16.15 | 19664994 | |
511 | Ubiquitination | CEVSVTPKTVTPASS EEEEEECCCCCCCCC | 46.38 | - | |
512 | O-linked_Glycosylation | EVSVTPKTVTPASSA EEEEECCCCCCCCCC | 30.71 | 28510447 | |
512 | Phosphorylation | EVSVTPKTVTPASSA EEEEECCCCCCCCCC | 30.71 | 26846344 | |
514 | Phosphorylation | SVTPKTVTPASSAKT EEECCCCCCCCCCCC | 20.54 | 15466863 | |
517 | O-linked_Glycosylation | PKTVTPASSAKTSPA CCCCCCCCCCCCCCH | 31.84 | 28510447 | |
517 | Phosphorylation | PKTVTPASSAKTSPA CCCCCCCCCCCCCCH | 31.84 | 26846344 | |
518 | Phosphorylation | KTVTPASSAKTSPAK CCCCCCCCCCCCCHH | 35.57 | 15466863 | |
520 | 2-Hydroxyisobutyrylation | VTPASSAKTSPAKQQ CCCCCCCCCCCHHHC | 52.03 | - | |
520 | Acetylation | VTPASSAKTSPAKQQ CCCCCCCCCCCHHHC | 52.03 | 25953088 | |
520 | Ubiquitination | VTPASSAKTSPAKQQ CCCCCCCCCCCHHHC | 52.03 | - | |
521 | Phosphorylation | TPASSAKTSPAKQQA CCCCCCCCCCHHHCC | 39.39 | 26846344 | |
522 | Phosphorylation | PASSAKTSPAKQQAP CCCCCCCCCHHHCCC | 23.35 | 15466863 | |
525 | Acetylation | SAKTSPAKQQAPPVR CCCCCCHHHCCCCCC | 46.45 | 7340157 | |
525 | Ubiquitination | SAKTSPAKQQAPPVR CCCCCCHHHCCCCCC | 46.45 | - | |
533 | Phosphorylation | QQAPPVRNLHQSGFS HCCCCCCCCCCCCCC | 41.95 | 24719451 | |
537 | O-linked_Glycosylation | PVRNLHQSGFSLSGA CCCCCCCCCCCCCCC | 30.93 | 28510447 | |
537 | Phosphorylation | PVRNLHQSGFSLSGA CCCCCCCCCCCCCCC | 30.93 | 30266825 | |
540 | Phosphorylation | NLHQSGFSLSGAQID CCCCCCCCCCCCCCC | 25.75 | 23401153 | |
542 | Phosphorylation | HQSGFSLSGAQIDDN CCCCCCCCCCCCCCC | 30.77 | 30266825 | |
554 | Phosphorylation | DDNIPRRTTQRIVAP CCCCCCCCCCEEECC | 28.67 | 22210691 | |
555 | Phosphorylation | DNIPRRTTQRIVAPP CCCCCCCCCEEECCC | 17.65 | 10818093 | |
565 | Asymmetric dimethylarginine | IVAPPGGRANITSLG EECCCCCCCCCCCCC | 30.31 | - | |
565 | Methylation | IVAPPGGRANITSLG EECCCCCCCCCCCCC | 30.31 | - | |
569 | Phosphorylation | PGGRANITSLG---- CCCCCCCCCCC---- | 20.08 | 23403867 | |
570 | O-linked_Glycosylation | GGRANITSLG----- CCCCCCCCCC----- | 27.57 | 28510447 | |
570 | Phosphorylation | GGRANITSLG----- CCCCCCCCCC----- | 27.57 | 29514088 | |
614 | Phosphorylation | ------------------------------------------------- ------------------------------------------------- | 24719451 | ||
619 | Phosphorylation | ------------------------------------------------------ ------------------------------------------------------ | 24719451 | ||
623 | Phosphorylation | ---------------------------------------------------------- ---------------------------------------------------------- | 24719451 | ||
626 | Phosphorylation | ------------------------------------------------------------- ------------------------------------------------------------- | 27251275 | ||
627 | Phosphorylation | -------------------------------------------------------------- -------------------------------------------------------------- | 24719451 | ||
642 | Phosphorylation | ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- | 24719451 | ||
645 | Phosphorylation | -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- | 24719451 | ||
647 | Phosphorylation | ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
32 | Y | Phosphorylation | Kinase | FYN | P06241 | Uniprot |
479 | Y | Phosphorylation | Kinase | FER | P16591 | PSP |
479 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
499 | Y | Phosphorylation | Kinase | FER | P16591 | PSP |
509 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
514 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
518 | S | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
518 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
522 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
522 | S | Phosphorylation | Kinase | DYRK2 | Q92630 | Uniprot |
555 | T | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
555 | T | Phosphorylation | Kinase | ROCK2 | O75116 | Uniprot |
555 | T | Phosphorylation | Kinase | ROCK-SUBFAMILY | - | GPS |
555 | T | Phosphorylation | Kinase | ROCK_GROUP | - | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPYL2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AP2A1_HUMAN | AP2A1 | physical | 12942088 | |
NUMB_HUMAN | NUMB | physical | 12942088 | |
DPYL1_HUMAN | CRMP1 | physical | 21900206 | |
DPYL4_HUMAN | DPYSL4 | physical | 21900206 | |
TBB5_BOVIN | TUBB | physical | 12134159 | |
LEF1_HUMAN | LEF1 | physical | 21988832 | |
HS105_HUMAN | HSPH1 | physical | 22863883 | |
PDE3A_HUMAN | PDE3A | physical | 22863883 | |
PUS7_HUMAN | PUS7 | physical | 22863883 | |
RNBP6_HUMAN | RANBP6 | physical | 22863883 | |
DPYL2_HUMAN | DPYSL2 | physical | 25416956 | |
DPYL3_HUMAN | DPYSL3 | physical | 25416956 | |
GORS2_HUMAN | GORASP2 | physical | 25416956 | |
DPYL5_HUMAN | DPYSL5 | physical | 25416956 | |
ARFP1_HUMAN | ARFIP1 | physical | 26344197 | |
NTM1A_HUMAN | NTMT1 | physical | 26344197 | |
VPS28_HUMAN | VPS28 | physical | 26344197 | |
DPYL2_HUMAN | DPYSL2 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509; THR-512; THR-514;SER-518; THR-521 AND SER-522, AND MASS SPECTROMETRY. | |
"Neurofibrillary tangle-associated collapsin response mediatorprotein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, andSer-522."; Gu Y., Hamajima N., Ihara Y.; Biochemistry 39:4267-4275(2000). Cited for: PHOSPHORYLATION AT SER-518; SER-522 AND THR-509, AND MUTAGENESIS OFSER-507; THR-509; THR-512; THR-514; SER-517; SER-518; THR-521 ANDSER-522. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-32, AND MASSSPECTROMETRY. | |
"Semaphorin3A signaling mediated by Fyn-dependent tyrosinephosphorylation of collapsin response mediator protein 2 at tyrosine32."; Uchida Y., Ohshima T., Yamashita N., Ogawara M., Sasaki Y.,Nakamura F., Goshima Y.; J. Biol. Chem. 284:27393-27401(2009). Cited for: PHOSPHORYLATION AT TYR-32 BY FYN. |